Clinical Trial Update: LAMA2-related Muscular Dystrophy Brain Study

View source ↗

Summary

A Cure CMD-sponsored brain study for LAMA2-related muscular dystrophy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lama2-related Muscular Dystrophy
• Merosin-deficient Congenital Muscular Dystrophy Mdc1a

Snippet

Sponsor: Cure CMD | Conditions: LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A) | Status: WITHDRAWN